Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Neural Interface Enables Quadriplegic to Perform Simple Tasks

By HospiMedica staff writers
Posted on 09 Aug 2006
A new study shows how the brain signals of a quadriplegic patient with spinal cord injury have been harnessed to enable the patient to shift a cursor on a computer screen and perform simple tasks.

Researchers at Massachusetts General Hospital (Boston, USA) have successfully utilized a new device called the BrainGate neural interface system to aid a 25-year-old quadriplegic patient who suffered a knife wound in 2001 that cut his spinal cord at the neck. More...
Using signals picked up by a sensor implanted in his brain that were then translated into electronic impulses, the patient was able to control a computer cursor to manipulate mechanical devices.

The patient underwent 57 sessions over nine months, during which time the implanted BrainGate sensor recorded activity in his motor cortex while the man imagined moving his paralyzed limbs. He then used that imagined motion in several computer-based tasks. Within little learning time, the patient began to be able to move a computer cursor via the BrainGate to open simulated e-mail, draw circular shapes, and play simple video games. He also was able to open and close a prosthetic hand and use a robotic limb to grasp and move objects. The findings were reported in the July 13, 2006, issue of Nature.

According to the researchers, the results suggest that the signals in the motor cortex are not only existent and remain active, but that they can be modulated voluntarily to perform actions that are similar to what those cells were doing before.

"One of the most exciting findings is that one part of the brain--the motor cortex that usually sends its signals down through the spinal cord to control movement--can still be used by this patient to control an external device, even after the spinal cord injury,” said lead researcher neurologist Dr. Leigh Hochberg.

The BrainGate system, developed by Cyberkinetics Neurotechnology Systems (Foxborough, MA, USA), is currently the subject of a clinical trial being conducted under an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA).



Related Links:
Massachusetts General Hospital
Cyberkinetics Neurotechnology Systems

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Newborn Hearing Screener
ALGO 7i
Medical Monitor
VITALMAX 4100SL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.